Magdalena Ignarska
Research Subjects
Magdalena Ignarska has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Justyna Ignarska
University Clinical Hospital No. 4 in Lublin, Doktora Kazimierza Jaczewskiego 8, 20-954 Lublin, Poland
7 shared publications - Oliwia Grygorczuk
Military Institute of Medicine - National Research Institute, Szaserów 128, 04-141, Warsaw, Poland
4 shared publications - Zuzanna Czach
Faculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland
4 shared publications - Dominika Bachurska
Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland
3 shared publications - Sabina Kubicz Mzabi
University Clinical Hospital No. 4 in Lublin, Doktora Kazimierza Jaczewskiego 8, 20-954 Lublin, Poland
3 shared publications - Agata Kromer
Uniwersytet Medyczny w Lublinie, Al. Racławickie 1 20-059 Lublin
1 shared publication
Latest Publications
- Open Access
- 29 October 2026
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
Use of Vacuum-Assisted Closure (VAC) along with Integra® Wound Matrix after a transmetatarsal amputation (TMA) following an accident caused by a mower – a case study
Introduction: Vacuum-Assisted Closure (VAC) is one of the modern-treatment methods for closing wounds using Integra® Wound Matrix, a matrix of 2 mm bovine collagen with a silicone layer, supporting collagen deposition and revascularisation. Case Report: He case is described of a patient who...
- 29 October 2026
- Published by Institute of Rural Health in Annals of Agricultural and Environmental Medicine
Open AccessUse of Vacuum-Assisted Closure (VAC) along with Integra® Wound Matrix after a transmetatarsal amputation (TMA) following an accident caused by a mower – a case study
Introduction: Vacuum-Assisted Closure (VAC) is one of the modern-treatment methods for closing wounds using Integra® Wound Matrix, a matrix of 2 mm bovine collagen with a silicone layer, supporting collagen deposition and revascularisation. Case Report: He case is described of a patient who...
- Open Access
- 4 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73502
The importance of breathing techniques in preventing pulmonary complications after surgery
Respiratory physiotherapy is an important element in the prevention and treatment of postoperative respiratory complications, which frequently occur in patients after surgical procedures, particularly in the thoracic and abdominal areas. The aim of this study was to assess the impact of respiratory physiotherapy on reducing the risk of postoperative pulmonary complications and to determine the importance of early mobilization and patient education in the rehabilitation process. The study is based on a review of available scientific literature regarding the use of various respiratory physiotherapy methods in the postoperative period and their effectiveness in preventing pulmonary complications. The analysis of studies indicates that the use of respiratory techniques reduces the incidence of complications such as atelectasis and pneumonia, and the best therapeutic effects are achieved when breathing exercises are combined with early patient mobilization and appropriate preoperative education. The results of the review confirm that a comprehensive approach to respiratory physiotherapy increases its effectiveness in preventing postoperative complications. At the same time, the need for further research of high methodological quality is emphasized to standardize procedures and better determine the effectiveness of individual therapeutic methods.
- 4 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73502
Open AccessThe importance of breathing techniques in preventing pulmonary complications after surgery
Respiratory physiotherapy is an important element in the prevention and treatment of postoperative respiratory complications, which frequently occur in patients after surgical procedures, particularly in the thoracic and abdominal areas. The aim of this study was to assess the impact of respiratory physiotherapy on reducing the risk of postoperative pulmonary complications and to determine the importance of early mobilization and patient education in the rehabilitation process. The study is based on a review of available scientific literature regarding the use of various respiratory physiotherapy methods in the postoperative period and their effectiveness in preventing pulmonary complications. The analysis of studies indicates that the use of respiratory techniques reduces the incidence of complications such as atelectasis and pneumonia, and the best therapeutic effects are achieved when breathing exercises are combined with early patient mobilization and appropriate preoperative education. The results of the review confirm that a comprehensive approach to respiratory physiotherapy increases its effectiveness in preventing postoperative complications. At the same time, the need for further research of high methodological quality is emphasized to standardize procedures and better determine the effectiveness of individual therapeutic methods.
- Open Access
- 9 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 92
Nutrition in COPD: From Malnutrition and Sarcopenia to Patient-Tailored Nutritional Strategies
Background: Malnutrition and sarcopenia are among the most prevalent and clinically significant extrapulmonary manifestations of chronic obstructive pulmonary disease (COPD), a widespread systemic condition. Nutritional depletion leads to impaired physical performance, worse quality of life, and increased exacerbation and mortality risk. Growing evidence suggests that nutritional therapy may play an important role in comprehensive COPD management. Aim: To present the current state of knowledge on the nutritional burden of COPD, its underlying mechanisms, and the effects of dietary and supplemental interventions. Methods: A total of one hundred two articles published between 2010 and 2026 were selected from databases such as PubMed, PMC, Cochrane Library, ScienceDirect and analysed based on their relevance and quality of evidence. Results: Malnutrition and sarcopenia are frequently observed in COPD and correlate with poorer functional status, increased exacerbation rate, and lower survival. Studies show that dietary patterns, depending on their composition, may exert protective effects or worsen disease progression. In addition to increasing body weight and fat-free mass (FFM), oral nutritional supplementation (ONS), when combined with pulmonary rehabilitation, may enhance muscle function and quality of life. Although long-term data remain limited, emerging evidence suggests potential benefits of antioxidants, polyunsaturated fatty acids (PUFAs), and microbiome-targeted therapies. Conclusion: Nutrition should be considered a key component of COPD management. Early nutritional assessment and individualized interventions may improve outcomes, particularly in patients with malnutrition or sarcopenia. Additionally, alongside ONS, patients with COPD should receive dietary counselling. Despite the growing body of research in this field, long-term randomized controlled trials are still required to optimize strategies and clarify effects on the gut–lung axis.
- 9 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 92
Open AccessNutrition in COPD: From Malnutrition and Sarcopenia to Patient-Tailored Nutritional Strategies
Background: Malnutrition and sarcopenia are among the most prevalent and clinically significant extrapulmonary manifestations of chronic obstructive pulmonary disease (COPD), a widespread systemic condition. Nutritional depletion leads to impaired physical performance, worse quality of life, and increased exacerbation and mortality risk. Growing evidence suggests that nutritional therapy may play an important role in comprehensive COPD management. Aim: To present the current state of knowledge on the nutritional burden of COPD, its underlying mechanisms, and the effects of dietary and supplemental interventions. Methods: A total of one hundred two articles published between 2010 and 2026 were selected from databases such as PubMed, PMC, Cochrane Library, ScienceDirect and analysed based on their relevance and quality of evidence. Results: Malnutrition and sarcopenia are frequently observed in COPD and correlate with poorer functional status, increased exacerbation rate, and lower survival. Studies show that dietary patterns, depending on their composition, may exert protective effects or worsen disease progression. In addition to increasing body weight and fat-free mass (FFM), oral nutritional supplementation (ONS), when combined with pulmonary rehabilitation, may enhance muscle function and quality of life. Although long-term data remain limited, emerging evidence suggests potential benefits of antioxidants, polyunsaturated fatty acids (PUFAs), and microbiome-targeted therapies. Conclusion: Nutrition should be considered a key component of COPD management. Early nutritional assessment and individualized interventions may improve outcomes, particularly in patients with malnutrition or sarcopenia. Additionally, alongside ONS, patients with COPD should receive dietary counselling. Despite the growing body of research in this field, long-term randomized controlled trials are still required to optimize strategies and clarify effects on the gut–lung axis.
- Open Access
- 15 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 69514
Type 2 Diabetes — A Disease of Small Vessels: Clinical Perspectives on Microangiopathy
Introduction and purpose:Type 2 diabetes mellitus (T2DM) is a major cause of microangiopathy, leading to structural and functional impairment of microcirculation. Diabetic microvascular dysfunction underlies key chronic complications, including retinopathy, nephropathy, neuropathy, and cardiomyopathy. The aim of this study was to summarize the pathophysiological mechanisms of diabetic microangiopathy and review current diagnostic methods for microcirculation assessment in T2DM. Review methods:A narrative review of the literature was conducted using PubMed and Google Scholar. Peer-reviewed studies published between 2000 and 2025 addressing microvascular complications of T2DM and diagnostic techniques for evaluating microcirculation were analyzed. State of knowledge:Chronic hyperglycemia induces endothelial dysfunction, basement membrane thickening, increased vascular permeability, and impaired tissue perfusion. These alterations contribute to progressive organ damage, often asymptomatic in early stages. Diagnostic tools range from classical methods such as fundus examination and fluorescein angiography to advanced non-invasive techniques including optical coherence tomography angiography (OCT-A), laser Doppler flowmetry (LDF), capillaroscopy, near-infrared spectroscopy (NIRS), and perfusion MRI. Summary:Early identification of microcirculatory disorders in T2DM is essential to prevent irreversible complications. The development of modern, predominantly non-invasive diagnostic methods increases the potential for earlier detection and improved clinical management.
- 15 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 69514
Open AccessType 2 Diabetes — A Disease of Small Vessels: Clinical Perspectives on Microangiopathy
Introduction and purpose:Type 2 diabetes mellitus (T2DM) is a major cause of microangiopathy, leading to structural and functional impairment of microcirculation. Diabetic microvascular dysfunction underlies key chronic complications, including retinopathy, nephropathy, neuropathy, and cardiomyopathy. The aim of this study was to summarize the pathophysiological mechanisms of diabetic microangiopathy and review current diagnostic methods for microcirculation assessment in T2DM. Review methods:A narrative review of the literature was conducted using PubMed and Google Scholar. Peer-reviewed studies published between 2000 and 2025 addressing microvascular complications of T2DM and diagnostic techniques for evaluating microcirculation were analyzed. State of knowledge:Chronic hyperglycemia induces endothelial dysfunction, basement membrane thickening, increased vascular permeability, and impaired tissue perfusion. These alterations contribute to progressive organ damage, often asymptomatic in early stages. Diagnostic tools range from classical methods such as fundus examination and fluorescein angiography to advanced non-invasive techniques including optical coherence tomography angiography (OCT-A), laser Doppler flowmetry (LDF), capillaroscopy, near-infrared spectroscopy (NIRS), and perfusion MRI. Summary:Early identification of microcirculatory disorders in T2DM is essential to prevent irreversible complications. The development of modern, predominantly non-invasive diagnostic methods increases the potential for earlier detection and improved clinical management.
- Open Access
- 5 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 68977
Therapeutic Plasmapheresis: Indications and Clinical Outcomes
Therapeutic plasma exchange is a procedure that involves separating plasma from the cellular components. The plasma that is taken out is discarded and swapped with a solution that includes both crystalloid and colloid components or fresh frozen plasma also.[1] Therapeutic plasmapheresis (TP) is used to treat autoimmune diseases, certain poisonings, and any other conditions where there is a need to rapidly eliminate toxins from the bloodstream. The most important part of plasmapheresis is separation plasma and exchange with plasma of donors. The change of action of the immune system is secondary. During the process, large amounts of plasma can be replaced without putting too much strain on the circulation.[2] This review provides us with information about plasmapheresis, comprehensive examination of its methods, indications, and effects within hematological disorders. It explores potential future directions for the development of plasmapheresis, shedding light on emerging trends and innovations in the field. The article provides a brief analysis of the advantages and disadvantages associated with the use of plasmapheresis. It also compares plasmapheresis to commonly employed treatment methods for a specific disease entity.
- 5 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88, 68977
Open AccessTherapeutic Plasmapheresis: Indications and Clinical Outcomes
Therapeutic plasma exchange is a procedure that involves separating plasma from the cellular components. The plasma that is taken out is discarded and swapped with a solution that includes both crystalloid and colloid components or fresh frozen plasma also.[1] Therapeutic plasmapheresis (TP) is used to treat autoimmune diseases, certain poisonings, and any other conditions where there is a need to rapidly eliminate toxins from the bloodstream. The most important part of plasmapheresis is separation plasma and exchange with plasma of donors. The change of action of the immune system is secondary. During the process, large amounts of plasma can be replaced without putting too much strain on the circulation.[2] This review provides us with information about plasmapheresis, comprehensive examination of its methods, indications, and effects within hematological disorders. It explores potential future directions for the development of plasmapheresis, shedding light on emerging trends and innovations in the field. The article provides a brief analysis of the advantages and disadvantages associated with the use of plasmapheresis. It also compares plasmapheresis to commonly employed treatment methods for a specific disease entity.
- Open Access
- 15 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Hypercalcemia of Malignancy: Diagnostic and Therapeutic Challenges
Background. Malignancy-associated hypercalcemia (HHM) is a frequent metabolic complication in advanced cancer, often leading to neurological deterioration, cardiovascular disturbances, reduced functional status, and shorter survival. In palliative care, timely diagnosis and management of HHM are essential to improve symptom control and patient comfort. Aim. To present a comprehensive, evidence-based review of current diagnostic and therapeutic approaches to hypercalcemia of malignancy, with a focus on palliative care settings. Material and methods. A narrative review was conducted using databases such as PubMed, MEDLINE, Google Scholar, and Europe PMC. Fifty-six articles published between 1994 and 2024 were selected based on clinical relevance and scientific quality. Results. Hypercalcemia in malignancy arises predominantly from PTHrP secretion, calcitriol overproduction, or local osteolysis. Diagnostic workup includes calcium profile, PTH/PTHrP levels, and imaging. Management involves intravenous hydration, bisphosphonates, denosumab, glucocorticosteroids, and—occasionally—calcitonin or hemodialysis. Timely treatment improves symptoms and may enable continuation of oncologic therapies. In palliative patients, hypercalcemia often necessitates a shift toward comfort-focused care and underscores the importance of interdisciplinary management. Conclusions. Malignancy-associated hypercalcemia significantly worsens prognosis and quality of life in advanced cancer. Individualized treatment—including rehydration, anti-resorptive agents, and symptom control—is essential. Effective calcium regulation alleviates suffering, facilitates supportive care, and should be integrated into comprehensive palliative strategies.
- 15 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessHypercalcemia of Malignancy: Diagnostic and Therapeutic Challenges
Background. Malignancy-associated hypercalcemia (HHM) is a frequent metabolic complication in advanced cancer, often leading to neurological deterioration, cardiovascular disturbances, reduced functional status, and shorter survival. In palliative care, timely diagnosis and management of HHM are essential to improve symptom control and patient comfort. Aim. To present a comprehensive, evidence-based review of current diagnostic and therapeutic approaches to hypercalcemia of malignancy, with a focus on palliative care settings. Material and methods. A narrative review was conducted using databases such as PubMed, MEDLINE, Google Scholar, and Europe PMC. Fifty-six articles published between 1994 and 2024 were selected based on clinical relevance and scientific quality. Results. Hypercalcemia in malignancy arises predominantly from PTHrP secretion, calcitriol overproduction, or local osteolysis. Diagnostic workup includes calcium profile, PTH/PTHrP levels, and imaging. Management involves intravenous hydration, bisphosphonates, denosumab, glucocorticosteroids, and—occasionally—calcitonin or hemodialysis. Timely treatment improves symptoms and may enable continuation of oncologic therapies. In palliative patients, hypercalcemia often necessitates a shift toward comfort-focused care and underscores the importance of interdisciplinary management. Conclusions. Malignancy-associated hypercalcemia significantly worsens prognosis and quality of life in advanced cancer. Individualized treatment—including rehydration, anti-resorptive agents, and symptom control—is essential. Effective calcium regulation alleviates suffering, facilitates supportive care, and should be integrated into comprehensive palliative strategies.
- Open Access
- 17 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 85, 66493
GLP-1 Receptor Agonists in Alcohol Use Disorder: Neurobiological Mechanisms and Therapeutic Potential
Alcohol use disorder (AUD) remains a significant global health challenge, characterized by compulsive alcohol intake, impaired control over consumption, and a high risk of relapse. Despite its widespread impact, pharmacological treatment options for AUD are limited and often insufficient. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for the treatment of type 2 diabetes and obesity, have recently gained attention for their potential to modulate reward-related behaviors and neurobiological pathways implicated in addiction. Preclinical studies in rodent models have demonstrated that agents such as dulaglutide, semaglutide, and liraglutide can reduce alcohol intake, reverse neurochemical disruptions in key brain regions, and alleviate anxiety and cognitive impairments associated with chronic alcohol exposure. These findings are supported by emerging clinical evidence, including randomized controlled trials and large-scale cohort studies, which suggest that GLP- 1RAs—particularly semaglutide—may reduce alcohol consumption and alcohol-related hospitalizations, especially in individuals with coexisting metabolic conditions. Although further randomized trials are needed to establish causality and define optimal treatment populations, GLP-1RAs hold substantial promise as a novel pharmacological approach in the treatment of AUD.
- 17 November 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 85, 66493
Open AccessGLP-1 Receptor Agonists in Alcohol Use Disorder: Neurobiological Mechanisms and Therapeutic Potential
Alcohol use disorder (AUD) remains a significant global health challenge, characterized by compulsive alcohol intake, impaired control over consumption, and a high risk of relapse. Despite its widespread impact, pharmacological treatment options for AUD are limited and often insufficient. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for the treatment of type 2 diabetes and obesity, have recently gained attention for their potential to modulate reward-related behaviors and neurobiological pathways implicated in addiction. Preclinical studies in rodent models have demonstrated that agents such as dulaglutide, semaglutide, and liraglutide can reduce alcohol intake, reverse neurochemical disruptions in key brain regions, and alleviate anxiety and cognitive impairments associated with chronic alcohol exposure. These findings are supported by emerging clinical evidence, including randomized controlled trials and large-scale cohort studies, which suggest that GLP- 1RAs—particularly semaglutide—may reduce alcohol consumption and alcohol-related hospitalizations, especially in individuals with coexisting metabolic conditions. Although further randomized trials are needed to establish causality and define optimal treatment populations, GLP-1RAs hold substantial promise as a novel pharmacological approach in the treatment of AUD.